OPYOppenheimer Holdings Inc.

The fair value estimate for NextNav has moved from US$5.00 to about US$6.67 per share, which is a shift of roughly 33% in the analyst model. Recent Street research, with its wide span of price targets and spectrum assumptions, helps explain why views on where NextNav could trade differ so much from this updated fair value. In the sections that follow, you will see how this evolving narrative may shape your own view on the stock over time. Analyst Price Targets don't always capture the full...

Ulta Beauty (ULTA) will likely meet second-quarter market expectations, though ongoing uncertainty a

Lemonade stock: what the upcoming Oppenheimer conference appearance could mean Lemonade (LMND) is set to present at the Oppenheimer 29th Annual Technology, Internet & Communications Conference on August 12, 2026, with CFO Timothy E. Bixby scheduled to speak. For investors watching Lemonade stock, the conference appearance offers an opportunity to hear management discuss the business, recent financial trends, and the company’s current thinking on growth and capital use. See our latest analysis...

Oppenheimer raised its SNOW price target to $400 as stronger customer consumption and growing CoCo adoption point to faster AI-driven growth.

Home improvement retailers Home Depot (HD) and Lowe's (LOW) second-quarter results are unlikely to s

One AI tool is becoming a bigger growth catalyst

Wayfair (W) could benefit from improving home furnishings demand, stronger internal programs, market

Target's (TGT) Q2 results should reflect continued traction with its turnaround efforts, with manage

Autodesk (ADSK) is seeing steady fiscal Q2 sales trends with limited disruption from its restructuri

Walmart (WMT) is back in focus after Oppenheimer shifted its rating to Perform from Outperform ahead of the August 20 earnings release, citing pharmacy related headwinds and what it views as a full valuation. See our latest analysis for Walmart. Walmart's share price has cooled from its all time high earlier in the year, with a 90 day share price return down 14.25%, even as the 1 year total shareholder return sits at 13.26% and the 5 year total shareholder return stands at 139.91%. Recent...

Walmart (NYSE:WMT) shares moved lower in U. S.

Oppenheimer believes WMT stock’s “peakish valuation” could be at risk of a re-rating lower if the company’s U.S. comp growth slows.

The second earnings season is going strong, and most areas of the stock market are taking part. This week, 138 S&P 500 companies are set to report results adding to the more than 300 names within the index that have already reported. S&P 500 profits have grown 57% from the year prior, more than beating estimates of less than 24%, research from Oppenheimer showed.

Shares of pet food company Freshpet (NASDAQ:FRPT) jumped 3.6% in the afternoon session after JP Morgan raised its price target on the stock and Oppenheimer noted the company is well-positioned to meet its financial goals. The investment bank maintained its Overweight rating on Freshpet while increasing its price target to $72.00 from $68.00, signaling a positive outlook. Adding to the bullish sentiment, analysts at Oppenheimer stated that the company is poised to deliver on its second-quarter ex

Oppenheimer on Thursday initiated coverage of Palisade Bio Inc., saying the stock offers investors an attractive way to gain exposure to the fast-growing inflammatory bowel disease market. The company’s lead candidate, PALI-2108, is a once-daily oral PDE4 inhibitor prodrug designed...

Oppenheimer Backs Microsoft Stock Ahead of Earnings Despite AI Capex Overhang

JFrog (FROG) faces strong Artifactory consumption, a robust pipeline, rising Curation demand, and gr

Oppenheimer Unveils Top Buy and Sell Stocks Across Every Sector

Analysts have updated their fair value estimate for NN to $5.00 from $5.75, signalling a recalibration of what they see as a reasonable price target for the stock right now. The change sits within a wide range of opinions, with more optimistic views tied to the potential spectrum value and more cautious stances focused on execution and profitability risks that could affect how quickly that value shows up in NN’s equity. As you read on, you will see how this evolving narrative may shape future...

ServiceNow (NOW) shares slipped about 0.7% to $102.50 in midday trading July 20 after CLSA began covering the enterprise-software company with an Underperform rating and a $72 price target, implying about 30% downside from the stock’s midday price. CLSA analyst Bhavtosh Vajpayee said ServiceNow’s ...

Analysts have trimmed their fair value estimate for Jack in the Box from about US$18.26 to roughly US$16.12, signaling a more cautious stance around what the stock might be worth today. The shift lines up with recent Street commentary, where many firms have cut price targets as they weigh softer sales trends, franchisee pressures, and the upcoming US$650m debt refinancing, alongside efforts to stabilize earnings. Read on to see what is driving these updates and how you can track the evolving...

The most dangerous moment for a stock is rarely when the skeptics pile on. It is when the last true believer quietly heads for the door. Wall Street runs on a simple hierarchy. There are the analysts who never liked a company, the ones who flip with the wind, and the rare few who plant a flag and ...

Oppenheimer Holdings (OPY) has drawn investor interest after a recent move in its share price, with the stock last closing at $119.03 and year to date total return data prompting closer scrutiny. See our latest analysis for Oppenheimer Holdings. Recent trading has been strong for Oppenheimer Holdings, with a 7 day share price return of 5.93% and a 30 day share price return of 11.19%. The year to date share price return of 63.86% and 5 year total shareholder return of 203.10% point to momentum...

We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. COMPASS Pathways plc (NASDAQ:CMPS) is one of the best psychedelic stocks on our list. TheFly reported on July 7 that Oppenheimer reaffirmed its Outperform rating and $20 price target on CMPS shares following new Phase 3 COMP006 26-week results. The firm […]

Oppenheimer is slashing its price target on the streaming giant, but it's not as bad as you might think.